Juliana Sopko

Juliana Sopko

Auto-generated profile, based on publicly available information

Juliana Sopko

Computational Epidemiology Lab, Boston Children's Hospital, 401 Park Drive, 7th Floor West, Boston, MA, 02215, United States, 1 617 355 8278

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2026 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
JSJuliana Sopko
Juliana Sopko
AHAimee R Han
Aimee R Han
JPJacqueline Powers
Jacqueline Powers
JSJacquelin A Sauer
Jacquelin A Sauer
MAMansi Avunoori
Mansi Avunoori
JBJohn S. Brownstein
John S. Brownstein
Background: Highly pathogenic avian influenza (HPAI) A(H5N1) clade 2.3.4.4b, a globally predominant strain, was introduced into poultry in the United States in 2022 via spillover from wild birds, and has since been regularly reported, posing ongoing risks to animal and human health. In 2024, the United States reported the first known HPAI A(H5N1) clade 2.3.4.4b infection in dairy cattle, rapidly evolving into a multispecies outbreak among cattle and poultry, with spillover into humans. Publicly available data remained siloed and fragmented, hindering timely response. Innovative multimodal surveillance methods can enhance situational awareness through comprehensive, standardized data collection, integration, and visualization. Objective: This study aimed to describe observations from the application of enhanced surveillance methods that collect, integrate, and visualize multimodal data for real-time tracking of the 2024‐2025 HPAI A(H5) outbreak in the United States as an innovative, transparent, repeatable, and scalable approach for open-source public health surveillance. Methods: Global.health conducted real-time, multimodal surveillance of the United States 2024‐2025 HPAI A(H5) outbreak using publicly available data for human cases (Centers for Disease Control and Prevention), animal outbreaks (United States Department of Agriculture), wastewater monitoring (WastewaterSCAN), genomic data (public genomic databases), research updates (scholarly communication), and policy changes and response measures (media and government) for the study period from February 1, 2024 through February 28, 2025. This digital data stream was used to create outbreak resources—an epidemiological linelist, event timeline, and interactive map—using a One Health framework to track emerging hotspots. Results: Global.health curated 70 confirmed human HPAI A(H5) cases across 13 states in a linelist, with exposure for nearly all (n = 65, 92.9%) cases associated with commercial agriculture and related operations. We curated 682 timeline entries across 6 distinct categories: human, cattle, response (eg, research, policy changes, and public health guidance), birds, genome, wastewater, and mammals. The map integrated human cases (n=70) and animal outbreaks (commercial cattle: n=977 and commercial poultry: n=325) into a single view. California was identified as the outbreak epicenter with high numbers of human cases (n=38, 54.3%), commercial cattle outbreaks (n=748, 76.6%), and commercial poultry outbreaks (n=66, 20.3%) during the study period. Wastewater surveillance detected the virus in California, with an unknown source at least 81 days before the first confirmed commercial dairy cattle case. Conclusions: Global.health’s approach for integrating traditional and nontraditional public health surveillance data within a One Health framework enhanced early situational awareness during the United States 2024‐2025 HPAI A(H5) outbreak, creating open access to resources that improve contextual understanding of the scope and evolution of this emerging zoonotic event. Further research should seek to understand the full potential of multimodal data in outbreak surveillance.

23 April 2025 in JMIR Preprints
Verified
Preprint
Open access
AGAutumn Gertz
Autumn Gertz
JSJuliana B Sopko
Juliana B Sopko
CRChristopher Remmel
Christopher Remmel
BRBenjamin Rader
Benjamin Rader
JBJohn S. Brownstein
John S. Brownstein
BACKGROUND Effective surveillance of seasonal influenza is crucial to understanding disease burden and impact. Traditional surveillance accounts for those who interact with the healthcare system. Understanding who is being captured by current surveillance methods can help further knowledge around influenza and identify areas of improvement. OBJECTIVE To examine influenza testing amongst a United States representative population to better understand who is testing over three seasons. METHODS Outbreaks Near Me is a participatory surveillance system that, in partnership with SurveyMonkey, conducted a weekly cross-sectional survey. Survey data from three influenza seasons was used, (2021-2022 flu season N = 335,964; 2022-2023 season N = 334,584; 2023-2024 season N = 267,940) with analysis conducted to examine influenza testing among different demographic groups. Descriptive proportions applying survey weights targeting U.S. census targets were produced to understand which demographics were testing for influenza. A weighted multivariate logistic regression was conducted for influenza testing by income, adjusting for other demographics and COVID-19 testing. RESULTS Generally, low levels of influenza testing were reported. Across all influenza seasons, those who had lower income tested for influenza at higher proportions. Lower household annual income was associated with higher odds of testing for influenza, while higher incomes were less likely to have been tested for influenza. CONCLUSIONS : Individuals who fall within lower income brackets tested at higher proportions and had an increased likelihood of having tested for influenza in the past 30 days than their higher income counterparts. These trends suggest that populations that may historically have more barriers to care, have access to and are using influenza tests.

21 October 2025 in JMIR Preprints
Verified
Preprint
Open access
JSJuliana Sopko
Juliana Sopko
AHAimee Han
Aimee Han
JPJacqueline Powers
Jacqueline Powers
JSJacqueline Sauer
Jacqueline Sauer
MAMansi Avunoori
Mansi Avunoori
JBJohn S. Brownstein
John S. Brownstein
BACKGROUND Highly pathogenic avian influenza (HPAI) outbreaks have primarily affected wild and domesticated bird populations, with occasional human spillover. In 2024, the United States (US) reported the first known HPAI H5N1 infection in dairy cattle, which rapidly evolved into a multispecies outbreak among cattle and poultry with spillover into humans. Publicly available data remained siloed and fragmented across agencies, which has implications for timely response. Innovative multimodal surveillance methods present an opportunity to enhance early situational awareness through comprehensive, standardized data collection, integration, and visualization. OBJECTIVE This study aimed to describe observations from the application of enhanced surveillance methods that collect, integrate, and visualize multimodal data for real-time tracking of the 2024-2025 HPAI outbreak in the US as an innovative, transparent, repeatable, and scalable approach for open source public health surveillance for zoonotic or other emerging or re-emerging pathogens. METHODS The Global.health consortium conducted real-time, multimodal data collection on the US HPAI outbreak between February 1, 2024 and February 28, 2025 using publicly available data for human cases, animal outbreaks, wastewater surveillance, genomic data, research updates, policy actions, and response measures. This digital data stream of traditional and non-traditional sources was used to create outbreak resources—a line-list, event timeline, and interactive map—using a One Health framework to track emerging hotspots RESULTS Seventy human HPAI cases were confirmed across 13 US states, with exposure for nearly all (92.9%) cases associated with commercial agriculture and related operations. Only one human case of HPAI had ever been documented in the US prior to 2024, underscoring a sharp rise in incidence. We curated 682 Timeline entries across six distinct categories: human, cattle, response, birds, genome, wastewater, and mammals. California was identified as the outbreak epicenter with leading numbers in human cases (n= 38, 54.3%), cattle (n=748, 76.6%), and poultry infections (n=66, 20.3%) during the study period. Wastewater surveillance provided an early warning sign, identifying viral presence in California at least 81 days before the first dairy cattle case. CONCLUSIONS The integration of traditional and non-traditional public health surveillance data into a single view within a One Health framework improved contextual understanding and enhanced situational awareness during the 2024-2025 HPAI outbreak in the US. Wastewater detections identified early viral presence, marking a critical window for intervention, policy action, and response to curb spread. Access to an open source multimodal data platform - like that put forward by Global.health - in real-time can assist researchers, public health officials, and decision makers in understanding the origins, scope, and evolution of emerging zoonotic diseases that fragmented, more traditional surveillance systems may be unable to readily provide. Further research should be conducted to understand the full potential of multimodal data in real-time outbreak surveillance.

26 August 2025 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
AGAutumn Gertz
Autumn Gertz
JSJuliana B Sopko
Juliana B Sopko
CRChristopher Remmel
Christopher Remmel
BRBenjamin Rader
Benjamin Rader
JBJohn S. Brownstein
John S. Brownstein
Background: Effective surveillance of seasonal influenza is crucial to understanding disease burden and impact. Traditional surveillance accounts for those who interact with the health care system, including those who are testing for diseases like influenza. However, care seeking and testing are not as common with influenza and can lead to bias. Better understanding who is being captured by current surveillance methods can help further knowledge around influenza and identify areas of improvement in surveillance, disease mitigation, and intervention efforts. Objective: This study aimed to examine who is testing for influenza amongst a United States representative survey population, across three seasons influenza seasons spanning 2021 to 2024. Methods: Outbreaks near me (ONM) is a participatory surveillance system that, in partnership with SurveyMonkey, conducted a web-based, weekly cross-sectional survey. ONM Survey data from three influenza seasons was used in this study: 2021‐2022, 2022‐2023, and 2023‐2024. Tested for influenza was defined as a “yes” response to “In the past 30 days, have you been tested for influenza (flu)?” Descriptive proportions applying survey weights reflecting US census targets were produced to understand which demographic groups were testing for influenza. A weighted multivariate logistic regression was conducted for influenza testing by income, adjusting for other demographics and COVID-19 testing. Descriptive proportions and multivariate regressions were conducted by influenza season. Results: In total, 940,172 responses were collected, with similar amounts in 2021‐2022 (n=335,964) and 2022‐2023 (n=334,584), and slightly less in 2023‐2024 (n=269,624). Generally, low levels of influenza testing were reported in each season at 4.2%, 9.1%, and 8.9%, respectively. Weighted proportions of those who tested for influenza only and no other diseases (like COVID-19) were even lower (0.4%, 971/335,964; 1.5%, 4,382/334,584; and 2.0%, 4579/269,624; respectively). Broadly, those who had lower income tested for influenza at progressively higher proportions. A similar trend was observed season to season with education level as well. Across the 3 observed influenza seasons, lower household annual income (under US $15,000) was associated with higher odds of testing for influenza (2021‐2022: adjusted odds ratio [AOR] 1.41, 95% CI 1.34‐1.48; 2022‐2023: AOR 1.42, 95% CI 1.35‐1.49; 2023‐2024: AOR 1.25, 95% CI 1.18‐1.34), while those with higher incomes (over US $150,000) were less likely to have been tested for influenza (2021‐2022: AOR 0.64, 95% CI 0.55‐0.86; 2022‐2023: AOR 0.82, 95% CI 0.73‐0.91; 2023‐2024: AOR 0.66, 95% CI 0.56‐0.76). Conclusions: Within this study population, individuals who fall within lower-income brackets tested for influenza more than their higher-income counterparts. In all 3 seasons spanning 2021‐2024, lower income was associated with higher proportions of influenza testing and an increased likelihood of having tested for influenza in the past 30 days. These trends suggest that populations that may experience more barriers to care are not only accessing influenza testing but doing so differently than groups that historically access care.